Tom Haviland. Worldwide Embalmers Surveys: Fibrous Blood Clots Remain Prevalent

Tom Haviland, a retired U.S. Air Force veteran and former contractor, embarked on a mission to validate claims regarding the presence of white fibrous blood clots—a notable and unsettling discovery showcased in the documentary "Died Suddenly" (2022). Triggered by Brian Hooker's revelation in the film, where he noted all embalmers at a professional conference acknowledging the emergence of these peculiar clots in mid-2021, Haviland felt compelled to investigate further.
In an exclusive interview with The New American, Mr. Haviland delves into his recent article, "Worldwide Embalmer Blood Clot Surveys Show Possible Link to Covid Vaccines," published by the magazine. He begins by recounting the abrupt end to his career as a defense contractor in October 2021, triggered by his refusal to comply with the Biden administration’s Covid vaccine mandate.
Regarding his surveys, Haviland emphasizes their meticulous design, aimed at ensuring maximum impartiality and focusing solely on empirical observations. Shockingly, a significant majority of embalmers from the United States, Canada, Britain, and Australia who participated in Haviland's surveys reported encountering an average of 30 corpses with these clots in 2022. By 2023, the incidence had declined to 20 percent. Haviland suspects that this may be explained by the dropping uptake of the Covid boosters. At the same time, that survey revealed the prevalence of microclots found in half of all embalmed bodies that year. Referred to as "dirty blood" in the documentary, this phenomenon has been previously associated primarily with chemotherapy.
Despite his efforts to disseminate these findings to federal healthcare agencies such as the U.S. Centers for Disease Control and Prevention (CDC), the U.S. Food and Drug Administration (FDA), and the National Institutes of Health (NIH), Haviland's endeavors were met with disregard. Similarly, outreach to embalmer associations across the United States yielded minimal response. Presently, Haviland collaborates with a select few catheterization labs specializing in fibrous clot extraction from living patients. The labs are cautious about speaking about the particulars of the work due to concerns about potential repercussions for their business.
Haviland believes that it would be best to stop Covid vaccinations until they are ruled out as causes of blood clots. He also warned of the goal of expanding the application of the mRNA platform to other vaccines, saying, “If this technology is indeed what's causing these clots, then we've got a major disaster in our hands.”
Tom Haviland can be reached at thomashaviland@sbcglobal.net.